Levels of PSMA and Numbers of Positive Cells Determine Success of Radioligand Therapy
Author(s) -
Gary D. Luker
Publication year - 2020
Publication title -
radiology imaging cancer
Language(s) - English
Resource type - Journals
ISSN - 2638-616X
DOI - 10.1148/rycan.2020204024
Subject(s) - prostate cancer , glutamate carboxypeptidase ii , radioligand , medicine , cancer research , targeted therapy , radiation therapy , cancer , oncology , prostate , metastasis , cancer cell , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom